Effects of muramyl dipeptide glycosides on lymphocyte proliferation and production of interleukin-2

Bulletin of Experimental Biology and Medicine

Volumn 134, Issue 2, 2002, Pages 161-164

  Kalyuzhin, O V ^a,b   Zemlyakov, A E ^a,b   Kalyuzhina, E V ^a,b   Shkalev, M V ^a,b   Nelyubov, M V ^a,b  

^a RESEARCH INSTITUTE OF HUMAN MORPHOLOGY   (Russian Federation)

^b TAURIDA NATIONAL V I VERNADSKY UNIVERSITY   (Ukraine)

Author keywords

Interleukin 2; Muramyl dipeptide glycosides; Proliferation

Indexed keywords

AGLYCON DERIVATIVE; GLYCOPEPTIDE; INTERLEUKIN 2; MURAMYL DIPEPTIDE DERIVATIVE; MURAMYL DIPEPTIDE GLYCOSIDE DERIVATIVE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE ALPHA CYCLOHEXYLGLYCOSIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE ALPHA HEPTYLGLYCOSIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE BETA ADAMANTYLGLYCOSIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE BETA BUTYLGLYCOSIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE BETA CYCLOHEXYLGLYCOSIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE BETA HEPTYLGLYCOSIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE BETA HEXYLGLYCOSIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE BETA NAPHTHYLGLYCOSIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE BETA OCTYLGLYCOSIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE BETA PHENETHYLGLYCOSIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE BETA PHENYLGLYCOSIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ACTIVITY; DRUG ANALYSIS; DRUG EFFECT; DRUG SYNTHESIS; GLYCOSYLATION; HOMEOSTASIS; IMMUNITY; IMMUNOSTIMULATION; IN VITRO STUDY; LYMPHOCYTE; MOUSE; NONHUMAN; SPLEEN CELL; STRUCTURE ANALYSIS;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ANIMALS; CELL DIVISION; GLYCOSIDES; INTERLEUKIN-2; LYMPHOCYTES; MICE;

ANIMALIA;

EID: 0036706613     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021140432374     Document Type: Article

References (11)

1. B. D. Brondz, T Lymphocytes and Their Receptors in Immunological Recognition [in Russian], Moscow (1987).
2. A. E. Zemlyakov, Muramyl Peptides: Synthesis and Biological Activity, Abstract of Doct. Chem. Sci. Dissertation, Odessa (2000).
3. O. V. Kalyuzhin, Zh. Mikrobiol., No. 1, 104-108 (1998).
4. O. V. Kalyuzhin, B. B. Fuks, N. V. Bovin, et al., Byull. Eksp. Biol. Med., 117, No. 5, 510-513 (1994).
5. B. F. Pinegin, T. M. Andronova, and M. I. Karsonova, Int. J. Immunorehabilitation, No. 6, 27-34 (1997).
6. R. M. Khaitov, I. S. Gushchin, B. F. Pinegin, and A. I. Zebrev, Manual of Experimental (Preclinical) Studies of New Drugs [in Russian], Moscow (2000), pp. 257-263.
7. E. Elouz, A. Adam, R. Cioburi, and E. Lederer, Biochem. Biophys. Res. Commun., 59, 1317-1325 (1974).
8. O. V. Kalyuzhin, A. E. Zemlyakov, and B. B. Fuchs, Int. J. Immunopharmacol., 18, No. 11, 651-659 (1996).
9. S. Kotani, M. Tsujimoto, T. Koga, et al., Fed. Proc., 45, No. 11, 2534-2540 (1986).
10. A. B. Reske-Kunz, H. Osawa, O. Josimovic-Alasevic, et al., J. Immunol., 138, No. 1, 192-196 (1987).
11. P. C. Stromberg, D. N. McMurray, and C. A. Brown, J. Clin. Lab. Immunol., 25, No. 2, 89-95 (1988).